相关实验视频

Updated: Apr 6, 2026

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model

Published on: May 21, 2013

社会经济领域的贫困与自主性淋巴细胞植入 (ACI) 后患者报告的较差结果有关

Salam T Ismael^1,2, Helen S McCarthy^3,4, Karina Wright^3,4

¹The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, UK.

|September 4, 2025

概括

来自较贫困地区的患者在自主性淋巴细胞植入 (ACI) 后的结果较差. 社会经济地位影响膝盖功能恢复,这表明针对弱势群体的支持可能会改善结果.

科学领域:

整形外科手术
复原医学
医疗服务研究

背景情况:

自主性软骨细胞植入 (ACI) 是一种用于修复软骨的手术.
患者报告的结果对于评估ACI成功至关重要.
社会经济因素可能影响临床结果.

研究的目的:

调查社会经济贫困和患者报告的结果在ACI发生1年后的关联.
确定邻居的剥夺是否影响膝盖ACI后的功能恢复.

主要方法:

对经历膝关节ACI的391名患者 (1996-2020年) 的回顾性分析.
使用多重贫困指数 (IMD) 量化社会经济贫困.
根据人口和基线因素进行调整,对1年的Lysholm分数进行线性回归分析.

主要成果:

随着地区贫困的增加,观察到较差的1年Lysholm分数.
高失业率,女性,以及较低的基线Lysholm分数与更糟糕的结果有关.
年龄,BMI,吸烟和收入不足没有显著影响结果.

结论:

邻居的社会经济贫困与ACI后的功能性结果有关.
未来的研究应该考虑社区贫困作为一个潜在的混因素.
对贫困地区的患者进行有针对性的干预可以提高ACI结果.

关键词:

体重指数自生性冠状细胞植入患者报告的结果整治工作社会经济上的贫困

更多相关视频

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro

Published on: May 17, 2017

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Published on: September 29, 2018

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.